Several bodies of evidence indicate that DUBs regulate the stability of PD-L1 protein and are linked to various cancer progressions, including breast cancer, hepatocellular carcinoma, gastric cancer, bladder cancer, ovarian cancer, and pancreatic cancer 36. This evidence concerns the gene CD274 and urinary bladder cancer.